酚妥拉明多巴胺地塞米松联合治疗肺心病心衰32例疗效观察

目的观察酚妥拉明、多巴胺、地塞米松联合治疗肺心病心衰的临床疗效。方法将住院的58例肺心病心衰患者随机分为治疗组（32例）和对照组（26例），所有病例给予吸氧、控制感染、解痉、适时强心利尿等常规治疗，治疗组在此基础上，加用酚妥拉明、多巴胺、地塞米松治疗。结果治疗组在心衰纠正时间和缩短病程方面均优于对照组（P〈0．01），治疗组总有效率93．7％，对照组总有效率76．9％，差异有统计学极显著意义（P〈0．01）。结论联合应用酚妥拉明、多巴胺、地塞米松治疗肺心病心衰效果显著。

Clinical Observation of phentolamine,dopamine and dexamethasone in treatment of 32 cases with pulmonary heart failure

Objective To observe clinical efficacy of phentolamine, dopamine, and dexamethasone in treatment of pulmonary heart failure. Methods Fifty-eight hospitalized heart failure patients with pulmonary heart disease were randomly divided into treatment group （32 patients） and control group （26 patients）. All patients were given oxygen, infection control, antispasmodic, diuretic, treatment as cardiac timely conventional therapy. Based on the normal treatment, treatment group was given phentolamine, dopamine and dexamethasone treatment. Results By comparing the two groups,treatment group were better than the control group in the correct time and shortening the course of disease （P 〈0. 01）. The total effective rate in treatment group was 93.7% ,while the control group was 76. 9%, the difference was statistically significant （ P 〈 0. 01 ）. Conclusion The combination of phentolamine, dopamine and dexamethasone treatment has remarkable effect in treatment of pulmonary heart failure.